Trexquant Investment LP Iveric Bio, Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$17.24 - $23.95 $458,273 - $636,638	26,582 Added 76.21%	61,460 $1.32 Million
Q3 2022 Nov 14, 2022	SELL	$9.4 - $18.59 $360,367 - $712,684	-38,337 Reduced 52.36%	34,878 $626,000
Q2 2022 Aug 11, 2022	BUY	$9.12 - $18.9 $667,720 - $1.38 Million	73,215 New	73,215 $704,000
Q3 2021 Nov 12, 2021	SELL	$7.07 - $17.5 $183,494 - $454,195	-25,954 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$5.69 - $7.17 $147,678 - $186,090	25,954 New	25,954 $164,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.